| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
OBJECTIVE: To characterize the relative contributions of the different abnormal Papanicolaou smear cytologic diagnoses in the Bethesda System to the subsequent histologic diagnosis of high-grade cervical neoplasia. METHODS: A total of 46,009 nonpregnant female members of the Kaiser Permanente Health Plan, Northern California Region, were studied prospectively. The main outcome measures included routine Papanicolaou smear diagnoses and subsequent histologic diagnosis of colposcopically directed cervical tissue specimens. RESULTS: Atypical squamous cells of undetermined significance (ASCUS) was the most common abnormal Papanicolaou diagnosis, representing 3.6% of the total number of smears. Of the total number of cases of histologically confirmed high-grade cervical neoplasia present in the population, the largest proportion (38.8%) was in women with smears showing ASCUS. Minimal abnormalities combined (ASCUS, atypical glandular cells of undetermined significance, and low-grade squamous intraepithelial lesion) were coincident with 68.6% of the cases of histologic high-grade cervical neoplasia diagnosed in this routine screening population. CONCLUSION: Recognition of the importance of equivocal and mild Papanicolaou test abnormalities in the subsequent diagnosis of high-grade cervical neoplasia emphasizes the need for accurate and cost-effective triage of the large population of women with minimally abnormal Papanicolaou diagnoses.
This article has been cited by other articles:
|
|
 |
|
  P. E. Castle, J. T. Cox, M. Schiffman, C. M. Wheeler, and D. Solomon Factors Influencing Histologic Confirmation of High-Grade Squamous Intraepithelial Lesion Cytology Obstet. Gynecol., September 1, 2008; 112(3): 637 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Wright, J. S. Rader, R. Davila, M. A. Powell, D. G. Mutch, F. Gao, and R. K. Gibb Human papillomavirus triage for young women with atypical squamous cells of undetermined significance. Obstet. Gynecol., April 1, 2006; 107(4): 822 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Kulasingam, J. J. Kim, W. F. Lawrence, J. S. Mandelblatt, E. R. Myers, M. Schiffman, D. Solomon, and S. J. Goldie Cost-Effectiveness Analysis Based on the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS) J Natl Cancer Inst, January 18, 2006; 98(2): 92 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Noller Cervical Cytology Screening and Evaluation Obstet. Gynecol., August 1, 2005; 106(2): 391 - 397. [Full Text] [PDF]
|
|
|
|
|
|
P. E. Castle, D. Solomon, M. Schiffman, C. M. Wheeler, and for the ALTS Group Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities J Natl Cancer Inst, July 20, 2005; 97(14): 1066 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Wright, R. M. Davila, K. R. Pinto, D. F. Merritt, R. K. Gibb, J. S. Rader, D. G. Mutch, F. Gao, and M. A. Powell Cervical Dysplasia in Adolescents Obstet. Gynecol., July 1, 2005; 106(1): 115 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Boardman, C. Stanko, S. Weitzen, and C. J. Sung Atypical Squamous Cells of Undetermined Significance: Human Papillomavirus Testing in Adolescents Obstet. Gynecol., April 1, 2005; 105(4): 741 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Harris, R. D. Burk, J. M. Palefsky, L. S. Massad, J. Y. Bang, K. Anastos, H. Minkoff, C. B. Hall, M. C. Bacon, A. M. Levine, et al. Incidence of Cervical Squamous Intraepithelial Lesions Associated With HIV Serostatus, CD4 Cell Counts, and Human Papillomavirus Test Results JAMA, March 23, 2005; 293(12): 1471 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Arbyn, F. Buntinx, M. V. Ranst, E. Paraskevaidis, P. Martin-Hirsch, and J. Dillner Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia J Natl Cancer Inst, February 18, 2004; 96(4): 280 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Sherman, S. S. Wang, C. M. Wheeler, L. Rich, P. E. Gravitt, R. Tarone, and M. Schiffman Determinants of Human Papillomavirus Load among Women with Histological Cervical Intraepithelial Neoplasia 3: Dominant Impact of Surrounding Low-Grade Lesions Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1038 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Solomon Chapter 14: Role of Triage Testing in Cervical Cancer Screening J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 97 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Lonky, J. C. Felix, Y. M. Naidu, and G. Wolde-Tsadik Triage of Atypical Squamous Cells of Undetermined Significance With Hybrid Capture II: Colposcopy and Histologic Human Papillomavirus Correlation Obstet. Gynecol., March 1, 2003; 101(3): 481 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Miller, H.-Y. Sung, G. F. Sawaya, K. A. Kearney, W. Kinney, and R. A. Hiatt Screening Interval and Risk of Invasive Squamous Cell Cervical Cancer Obstet. Gynecol., January 1, 2003; 101(1): 29 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Kim, T. C. Wright, and S. J. Goldie Cost-effectiveness of Alternative Triage Strategies for Atypical Squamous Cells of Undetermined Significance JAMA, May 8, 2002; 287(18): 2382 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Wright Jr, J. T. Cox, L. S. Massad, L. B. Twiggs, E. J. Wilkinson, and for the 2001 ASCCP-Sponsored Consensus Conference 2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities JAMA, April 24, 2002; 287(16): 2120 - 2129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M M. Manos HPV testing for clarifying borderline cervical smear results BMJ, April 14, 2001; 322(7291): 878 - 879. [Full Text]
|
|
|
|
|
|
G. Rebello, N. Hallam, G. Smart, D. Farquharson, and J. McCafferty Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study BMJ, April 14, 2001; 322(7291): 893 - 894. [Full Text]
|
|
|
|
|
|
E. R. MYERS, D. C. MCCRORY, S. SUBRAMANIAN, N. MCCALL, K. NANDA, S. DATTA, and D. B. MATCHAR Setting the Target for a Better Cervical Screening Test: Characteristics of a Cost-Effective Test for Cervical Neoplasia Screening Obstet. Gynecol., November 1, 2000; 96(5): 645 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. SHLAY, T. DUNN, T. BYERS, A. E. BARON, and J. M. DOUGLAS JR Prediction of Cervical Intraepithelial Neoplasia Grade 2-3 Using Risk Assessment and Human Papillomavirus Testing in Women With Atypia on Papanicolaou Smears Obstet. Gynecol., September 1, 2000; 96(3): 410 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. BERGERON, D. JEANNEL, J.-D. POVEDA, P. CASSONNET, and G. ORTH Human Papillomavirus Testing in Women With Mild Cytologic Atypia Obstet. Gynecol., June 1, 2000; 95(6): 821 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Leidy, R. Brown, B. Luce, E. Sheets, T. V. Sedlacek, A. D. Brown, and A. M. Garber Cost-effectiveness of Methods to Enhance Sensitivity of Papanicolaou Testing JAMA, October 20, 1999; 282(15): 1419 - 1420. [Full Text] [PDF]
|
|
|
|
|
|
M. M. Manos, W. K. Kinney, L. B. Hurley, M. E. Sherman, J. Shieh-Ngai, R. J. Kurman, J. E. Ransley, B. J. Fetterman, J. S. Hartinger, K. M. McIntosh, et al. Identifying Women With Cervical Neoplasia: Using Human Papillomavirus DNA Testing for Equivocal Papanicolaou Results JAMA, May 5, 1999; 281(17): 1605 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Cox Evaluating the Role of HPV Testing for Women With Equivocal Papanicolaou Test Findings JAMA, May 5, 1999; 281(17): 1645 - 1647. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
